In this study, we investigated the efficacy of curcumin analog C1 in three AD animal models, which represent the APP pathology (5xFAD mice), tauopathy (P301S Tau mice) and the APP/MAPT combined pathology (3xTg‐AD mice). This evidence concerns the gene MAPT and tauopathy.